阿尔茨海默病外周血淀粉样蛋白beta检及临床应用研究
[Abstract]:Objective amyloid protein cascade hypothesis suggests that amyloid beta (Amyloid beta, A beta) is an important cause for the development of Alzheimer's disease (Alzheimer 's Disease, AD). The formation of senile plaques with A beta as the main component of the neuronal cells in the cortical and hippocampal regions of the brain tissue has become a diagnostic marker for AD. At present, A However, the neuroimaging diagnosis method can provide evidence for the diagnosis of AD, but the metabolic clearance of the tracer is not yet determined, and it is difficult to evaluate the side effects of the human body. The purpose of this paper is to establish a simple method for detecting A beta in peripheral blood and to explore the role of A beta in the diagnosis and pathogenesis of AD in peripheral blood. Compared with the detection of neuroimaging markers and cerebrospinal fluid markers, the peripheral specimen is simple. It has a great advantage in the diagnosis, treatment, and pathogenesis of the disease. Method 1. according to the strict inclusion and discharge standards, 50 cases of AD patients (group AD) of General Hospital Affiliated to Tianjin Medical University neurology from March 2012 to October 2014, 50 cases of sex and age matched healthy persons (Group HC) were selected. The EDTA-2Na anticoagulant.2. used protein immunoblotting (Western blot, WB) and immunofluorescence experiments to confirm the presence of A beta fiber / aggregation.3. on the erythrocyte membrane and the specificity of the sulphur T (Thioflavin-T, Th T) on the plasma and erythrocyte membrane. The fluid physics index and blood lipid level were detected and analyzed in group.5.AD and group HC, the volume of peripheral blood increased red blood cells, and the volume of red blood cells increased in AD group and the correlation.6. of simple intelligence state (Simple mental state examination, MMSE) in Th T specificity test. The number of Th T specific test positive individuals in group AD and HC group accounted for the percentage of the total subjects, and the percentage of Th T positive red cells accounted for the percentage of the total red cell number.8. through Leica Application Suit 2.0.1 software, the morphology of the positive erythrocytes was analyzed by the Leica Application Suit 2.0.1 software. Results the plasma amyloidosis fluorescence intensity of the group was strong. The plasma amyloid fluorescence intensity of the plasma (16.63 + 5.67) U/ml and (12.83 + 0.27) U/ml.AD was significantly higher than that of the control group (P0.05) and the whole blood viscosity (18.16 + 3.6) (18.16 + 3.6), (17.92 + 0.4) m Pa.s, and two groups of P0.05, and the whole blood viscosity (8.64 + 5 1/s) were respectively (8.64 + 1.45) and m 18.16 respectively. The whole blood viscosity (low cut 30 1/s) was (5.32 + 0.76), (5.09 + 0.16) m Pa.s, and the two group was P0.05, and the whole blood viscosity (200 1/s) was (4.16 + 0.54), (3.74 + 0.15) m Pa.s, and the two group was P0.05, and the plasma concentration was respectively (1.40 +), m Pa.s and P0.05; erythrocyte sedimentation, respectively, mm/h, respectively. The group was compared with P0.05, the hematocrit was (0.43 + 0.61), (0.45 + 0.31), and the two groups were compared with P0.05, the whole blood high cutting relative index was (2.94 + 0.22), (2.74 + 0.26), and two group was P0.05, and the whole blood low shear relative index was (12.79 + 1.78), (14.24 + 0.45) and P0.05, and the K value of the erythrocyte sedimentation equation was respectively. The erythrocyte aggregation index was (4.34 + 0.36), (4.13 + 0.14), and the two group was compared with P0.05, and the low reduction viscosity of the whole blood was (38.36 + 2.77), (38.81 + 2.50) m Pa.s, and two group was P0.05, and the whole blood high reduced viscosity was (6.33 + 0.40), (6.19 + 0.49) m Pa.s and P0.05, and the erythrocyte rigidity index was respectively (4.70 + 0.50) m Pa.s, two groups were compared with P0.05, erythrocyte deformation index TK was (0.82 + 0.08), (0.81 + 0.07). The total cholesterol in group P0.05.3.AD and HC group was respectively (4.71 + 1.24), (3.95 + 0.22) mmol/L, two group was P0.05, and high density lipoprotein was (two) mmol/L, P0.05 and low density lipoprotein. Don't be (2.70 + 0.84), (2.78 + 0.36) mmol/L, two groups compared the whole blood viscosity (high cut part) of group P0.05.4.AD, plasma amyloidosis degree, serum total cholesterol content correlation, its correlation can be used regression equation Y? =2.798+0.070X1+0.027X2 (Y?, whole blood viscosity high cut; X1, plasma amyloidosis degree; X2, total cholesterol) indicated.5.AD volume increase The number of large erythrocytes (16.8%) was significantly higher than that in the HC group (6.7%) (P0.01), and the number of red blood cells in the AD group was negatively correlated with MMSE (r=-0.773).6.Th T can specifically identify the A beta fibers / aggregates on the erythrocyte membrane, and the staining results were not subject to the plasma interference of.7.AD group 98%, the Th T specificity test was positive, and its Th positive red cells were 100%. The ratio range was (2%-30%); the percentage of Th T specific test positive individuals in group HC was 38%, and the positive rate fluctuated in (2%-3.4%).8.A beta fiber / aggregation and red blood cells resulting in increased erythrocyte volume and morphogenesis, mainly in 4 types. Conclusion 1. analysis of plasma amyloidosis, total cholesterol level and blood physical index in AD patients. Results three biomarkers were significantly higher than those in the HC group, and the level of plasma amyloidosis was related to the total cholesterol level and the plasma physical index of the whole blood viscosity (high shear part). It may be used as an auxiliary examination index.2. to explore a method for detecting amyloidosis in blood cells, and to detect the amyloidosis of blood red cells, granulocytes and monocytes. This method can be used to detect the clinical range of amyloidosis in AD patients with amyloidosis.3. for the first time. It is determined that the percentage of amyloid erythrocytes in AD patients is (2%-30%), and may be used as an auxiliary examination of AD patients.4. to find that Th T can specifically identify the.Th T positive of A beta fiber / aggregation on the erythrocyte membrane in the peripheral circulation. The morphological changes of erythrocyte suggest that A beta fibers/aggregates may lead to morphological changes of erythrocyte, indicating that cellular amyloidosis may participate in the pathological mechanism of AD.
【学位授予单位】:天津医科大学
【学位级别】:硕士
【学位授予年份】:2015
【分类号】:R749.16;R446.1
【相似文献】
相关期刊论文 前10条
1 刘红春,张顺财;淀粉样变[J];肝脏;2000年03期
2 史玉玲;何桂兰;;异维A酸治疗原发性皮肤淀粉样变临床观察[J];医学研究通讯;2001年03期
3 刘小军,潘康俭;原发性皮肤淀粉样变109例临床和病理分析[J];皮肤病与性病;2002年04期
4 邓安国,苏华;继发性肾淀粉样变的发病机制与治疗[J];临床内科杂志;2002年06期
5 李雁,彭德荣;异维A酸治疗32例原发性皮肤淀粉样变临床观察[J];中国厂矿医学;2005年03期
6 Parsi K. ,Kossard S. ,张宪旗;热敏苔癣状淀粉样变[J];世界核心医学期刊文摘(皮肤病学分册);2005年05期
7 李别非,江亚文;系统性淀粉样变1例[J];中国老年学杂志;2005年11期
8 李祖海;余英豪;;淀粉样变误诊为原发性肾病综合征2例报告[J];安徽医学;2006年05期
9 刘莹;张辉;倪然;张筠;;系统性淀粉样变26例临床分析[J];医药论坛杂志;2010年14期
10 黄志英;陈广田;;肺结核Ou发淀粉样变两例报告[J];中国防痨杂志;1965年02期
相关会议论文 前10条
1 ;系统性淀粉样变1例[A];2005年浙江皮肤性病学学术年会论文汇编[C];2005年
2 吕中法;;皮肤淀粉样变?[A];2009年浙江省皮肤病学术会议论文汇编[C];2009年
3 房丽华;蒋明;;原发性干燥综合征合并淀粉样变三例[A];中华医学会全国风湿病学年会论文汇编[C];2003年
4 徐凌;蔡柏蔷;钟旭;朱元珏;;淀粉样变的呼吸系统表现59例分析[A];中华医学会第七次全国呼吸病学术会议暨学习班论文汇编[C];2006年
5 彭建中;;局限性结节性原发性皮肤淀粉样变1例[A];2008全国中西医结合皮肤性病学术会议论文汇编[C];2008年
6 蔡绥R,
本文编号:2166986
本文链接:https://www.wllwen.com/huliyixuelunwen/2166986.html